Podcast Journal Club

Osteopenia as a Surgical Indication in Primary Hyperparathyroidism

August 22, 2024

EFL052

Join host Chase Hendrickson, MD, from Vanderbilt University Medical Center, in a discussion about a recent article in The Journal of Clinical Endocrinology & Metabolism about the benefits of surgical cure of primary hyperparathyroidism in women with osteopenia. He talks with Alyson Myers, MD, from Albert Einstein College of Medicine, and guest expert Natalie Cusano, MD, from the Zucker School of Medicine at Hofstra University and the Lenox Hill Hospital in New York. The article featured this month, by Frey et al, was published in the June 2024 issue of JCEM: “Parathyroidectomy Improves Bone Density in Women With Primary Hyperparathyroidism and Preoperative Osteopenia.”

Meet the Speakers

Natalie Cusano and Alyson Myers

Natalie Cusano, MD, is a professor of medicine at the Zucker School of Medicine at Hofstra/Northwell and director of the Bone Metabolism Program in the Division of Endocrinology at Lenox Hill Hospital in New York. She received her undergraduate training at the Massachusetts Institute of Technology and her medical training at the Boston University School of Medicine. She completed residency training in internal medicine at Beth Israel Deaconess Medical Center and fellowship training in endocrinology, diabetes, and metabolism at the College of Physicians & Surgeons, Columbia University. Dr. Cusano serves on the editorial board of Endocrine Practice and writes the questions for the calcium and bone section of the Endocrine Society Endocrine Board Review. She lists more than 100 publications of original research, invited articles, chapters and abstracts in the field of metabolic bone disease.

Alyson Myers, MD, is an associate professor and the Associate Chair for Diversity, Equity, and Inclusion for the Department of Medicine at Montefiore/Albert Einstein in the Bronx, N.Y. She also is an adjunct associate professor at the Zucker School of Medicine at Hofstra/Northwell, where she also served as the medical director of inpatient diabetes for North Shore University Hospital from 2013–2021. Dr. Myers attended the University of Virginia, where she majored in French and minored in chemistry. After college, she returned home to Queens, N.Y., to teach junior high school math and science. A year later, she attended SUNY Downstate for medical school, where she was the four-year recipient of the President’s Award Scholarship. She completed a five-year combined internal medicine/psychiatry residency at Rush University Medical Center in Chicago. During her fourth year, she was chief resident. After residency, she completed an endocrinology fellowship at the University of Texas Southwestern. During fellowship, she received a T32 training grant in mood disorders and diabetes under the mentorship of Madhukar Trivedi, MD. In 2022, Dr. Myers was co-awarded a Center for Diabetes Translational Research grant to further examine and improve the health outcomes of persons with diabetic foot ulcers. Her goal is to lower the high rate of amputations of Black and Brown persons with diabetes in the Bronx by using multidisciplinary care and limb salvage techniques. Dr. Myers has several publications on the topics of diabetes disparities and diabetes technology. She has been a long-time reviewer for several journals, including: Journal of Immigrant and Minority Health, Journal of Diabetes Science and Technology, and Diabetes Care. In 2023, she was the editor of Diabetes and COVID-19: Considerations and Clinical Management. Also, she is an active member of the Endocrine Society as an abstract reviewer, member of the Publications Core Committee, and a co-lead for the ExCEL Program, which provides leadership training for endocrine fellows and early career attendings. Dr. Myers has served two terms on the American Board of Endocrinology, Diabetes, & Metabolism.

Resources


Subscribe

Stay up to date by copying this link into your podcast player or:

Apple Podcasts
Spotify
YouTube

Last Updated:
Back to top

Who We Are

For 100 years, the Endocrine Society has been at the forefront of hormone science and public health. Read about our history and how we continue to serve the endocrine community.